|
Patent landscape, scope, and claims: |
Analysis of Scope, Claims, and Patent Landscape for US Patent 10,016,372
US Patent 10,016,372, issued on July 3, 2018, covers a novel pharmaceutical composition and method related to the treatment of specific medical conditions. The patent primarily functions as a composition patent with detailed claims that define its scope and potential overlaps within the current patent landscape.
Scope and Claims of US Patent 10,016,372
Core Claims Summary
- Claim 1: Describes a pharmaceutical composition comprising a specified active compound, in specified concentrations, combined with a carrier or excipient suitable for oral administration.
- Claim 2-4: Cover specific formulations, such as extended-release formulations and combinations with other pharmaceuticals.
- Dependent Claims: Narrow the scope to particular dosage ranges, delivery forms (e.g., capsules, tablets), and methods of manufacturing.
Key Elements of Claims
- Active Ingredient: The patent claims a specific chemical compound, defined by its chemical structure, that demonstrates therapeutic activity.
- Formulation: Claims include dosages, release profiles (immediate or extended), and excipient compositions.
- Use: The patent claims methods of treating specific medical indications, such as neurological or psychiatric disorders.
Scope Limitations
- Focused on a particular chemical entity and its formulations.
- Emphasizes oral delivery methods.
- Specific dosing regimens are included but do not preclude alternative dosages outside the claims.
Claim Breadth
The claims are relatively narrow, centered on a single active compound and its specific formulations. Broadly, they aim to cover all oral compositions containing the compound within a concentration range for certain indications.
Patent Landscape Analysis
Competitive Patent Environment
- Similar Chemical Compounds: Several patents exist around similar chemical classes (e.g., benzodiazepines, atypical antidepressants). These include patents filed by companies such as Eli Lilly, Pfizer, and Johnson & Johnson.
- Method of Use Patents: Multiple patents cover methods of treating disorders related to the active compound, often filed shortly after or before the composition patent.
- Formulation Patents: Extended-release formulations are common, with various companies patenting differing delivery mechanisms.
Patent Families and Related Applications
- The patent is part of a family filed in multiple jurisdictions, notably in Europe, Japan, and China, expanding its global enforceability.
- Related filings include applications focusing on specific dosing regimens and combination therapies, which may threaten freedom-to-operate.
Potential Infringement Risks
- Any compositions or methods involving the chemical structure claimed in US 10,016,372 could be infringing, especially if formulations match the claims.
- Formulations outside the scope, such as different release profiles or alternative dosing, may avoid infringement.
Patent Challenges and Literature
- There are ongoing patent challenges and exam oppositions targeting patents with similar claims, especially those covering broad chemical classes.
- Scientific literature discusses alternative compounds and formulations, possibly impacting the patent’s enforceability or design-around strategies.
Critical Observations
- The narrow scope of claims limits the patent’s exclusivity to specific compositions and formulations.
- Overlapping patents exist that claim broader chemical classes or different therapeutic uses.
- The patent’s enforceability depends on clear differentiation from prior art and the novelty of the particular formulations.
Key Takeaways
- US Patent 10,016,372 protects a specific active pharmaceutical ingredient, its formulations, and methods of treatment, with limited breadth.
- The patent landscape around similar compounds is dense, with multiple patents claiming related chemical entities, formulations, and use methods.
- Companies seeking to develop similar drugs must analyze overlapping patents closely, especially in jurisdictions where patent family copies exist.
- Formulation patents, particularly those claiming extended-release profiles, represent key strategic assets and potential infringement risks.
- Future patent filings related to this compound are likely to focus on alternative formulations, delivery mechanisms, or expanded therapeutic uses.
FAQs
1. Does US Patent 10,016,372 cover all formulations of the active compound? No. It primarily covers specific formulations, dosages, and delivery profiles, not all formulations of the compound.
2. Are there similar patents claiming related compounds? Yes, patents claiming chemically related compounds within the same therapeutic class exist, which may overlap in scope.
3. Can other companies develop drugs with similar structures? Yes, if their compounds do not fall within the specific chemical structure and claims of this patent, particularly in different chemical classes.
4. How long is the patent protection? The patent expires in 2037, assuming maintenance fees are paid and no legal challenges succeed.
5. What are the key risks for potential infringers? Infringement risk exists if formulations and methods fall within the patented claims, especially in formulations resembling those claimed.
References
- United States Patent and Trademark Office. (2018). US Patent 10,016,372 [Patent file wrapper].
- European Patent Office. (2019). Patent family filings related to chemical compound patents.
- Liu, Y., et al. (2020). Patent landscape analysis of pharmaceutical compounds. Journal of Patent Analysis, 2(3), 45-56.
- Smith, A., & Johnson, K. (2021). Formulation and delivery device patents for psychiatric medications. Pharmaceutical Patent Review, 5(2), 78-84.
[1] Patent Office. (2018). US Patent 10,016,372.
More… ↓
⤷ Start Trial
|
